Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”
- 27 June 2023
- journal article
- letter
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 24 (5) , 855-858
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Living alone and all-cause mortality in community-dwelling adults: A systematic review and meta-analysiseClinicalMedicine, 2022
- Optimal approximate conversions of odds ratios and hazard ratios to risk ratiosBiometrics, 2019
- The “Hispanic mortality paradox” revisited: Meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants' mortalitySocial Science & Medicine, 2017
- Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysisEuropean Journal of Gastroenterology & Hepatology, 2016
- Isotretinoin Exposure and Risk of Inflammatory Bowel DiseaseJAMA Dermatology, 2014
- Risk of Inflammatory Bowel Disease From Isotretinoin: A Case-Control StudyAmerican Journal of Gastroenterology, 2014
- Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Population-Based Cohort StudyJournal of Investigative Dermatology, 2013
- Systematic review and meta-analysis methodologyBlood, 2010
- Isotretinoin Is Not Associated With Inflammatory Bowel Disease: A Population-Based Case–Control StudyAmerican Journal of Gastroenterology, 2009
- What's the Relative Risk?JAMA, 1998